Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Priority Technology Holdings, Inc.Priority Technology Holdings Reports 6.3% Revenue Growth to $241.4 Million in Q3 2025
Ares Management CorpAres Management Reports 47% Revenue Growth to $1.66 Billion in Latest Quarter
ORRSTOWN FINANCIAL SERVICES INCOrrstown Financial Services Reports $21.9 Million Net Income in Q3 2025
Playtika Holding Corp.Playtika Reports 8.7% Revenue Growth to $674.6 Million in Q3 2025
Aligos Therapeutics, Inc.Aligos Therapeutics Reports $31.5 Million Net Loss in Q3 2025, Increased Operating Expenses
SOLAREDGE TECHNOLOGIES, INC.SolarEdge Technologies Reports 44.5% Revenue Growth and Significant Profitability Turnaround in Q3 2025
Disc Medicine, Inc.Disc Medicine Reports $62.3 Million Net Loss in Q3 2025, Driven by Increased R&D Expenses
STEWART INFORMATION SERVICES CORPStewart Information Services Reports 20% Revenue Growth and Increased Net Income in Q3 2025
Seadrill LtdSeadrill Reports Q3 2025 Revenue Increase but Net Loss of $11 Million
SCANSOURCE, INC.ScanSource Reports $739.7M in Net Sales, 4.6% Decrease Year-Over-Year
Clear Secure, Inc.Clear Secure Reports 16% Revenue Growth to $229.2 Million in Latest Quarter
QNB CORPQNB Corp. Reports Increased Net Income and Plans Acquisition of The Victory Bancorp
ACORN ENERGY, INC.Acorn Energy Reports 22% Revenue Growth for Nine Months Ending September 30, 2025
Solo Brands, Inc.Solo Brands Reports 43.7% Decline in Q3 2025 Net Sales, Net Loss of $22.9 Million
National Vision Holdings, Inc.National Vision Holdings Reports 7.9% Revenue Growth to $487.3 Million in Q3 2025
Rallybio CorpRallybio Corporation Reports $16M Net Income in Q3 2025, Driven by Joint Venture Sale
Leatt CorpLeatt Corporation Reports 18% Revenue Growth to $14.34 Million in Latest Quarter
GOLDEN ENTERTAINMENT, INC.Golden Entertainment Reports 4% Revenue Decline in Q3 2025
MBX Biosciences, Inc.MBX Biosciences Reports $21.6 Million Net Loss in Latest Quarter, Increases R&D Spending
SANGAMO THERAPEUTICS, INCSangamo Therapeutics Reports 98.8% Revenue Decline and Financial Challenges
International Seaways, Inc.International Seaways Reports Decline in Q3 2025 Financial Performance
Replimune Group, Inc.Replimune Group Reports $83.1 Million Net Loss in Q2 Fiscal 2025
PATRICK INDUSTRIES INCPatrick Industries Reports 6% Net Sales Increase to $975.6 Million in Q3 2025
RAPT Therapeutics, Inc.RAPT Therapeutics Reports $17.6 Million Net Loss in Q3 2025, Sees Improvement in Financial Position
BlackRock TCP Capital Corp.BlackRock TCP Capital Corp. Reports Q3 Financial Results with Decrease in Net Investment Income